annual EBIT:
-$425.74M-$34.25M(-8.75%)Summary
- As of today (August 3, 2025), AGIO annual earnings before interest & taxes is -$425.74 million, with the most recent change of -$34.25 million (-8.75%) on December 31, 2024.
- During the last 3 years, AGIO annual EBIT has fallen by -$47.32 million (-12.50%).
- AGIO annual EBIT is now -2459.90% below its all-time high of -$16.63 million, reached on December 31, 2011.
Performance
AGIO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$106.63M+$18.41M(+14.72%)Summary
- As of today (August 3, 2025), AGIO quarterly earnings before interest & taxes is -$106.63 million, with the most recent change of +$18.41 million (+14.72%) on March 31, 2025.
- Over the past year, AGIO quarterly EBIT has dropped by -$14.56 million (-15.81%).
- AGIO quarterly EBIT is now -3423.85% below its all-time high of $3.21 million, reached on September 30, 2014.
Performance
AGIO quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$440.29M-$14.56M(-3.42%)Summary
- As of today (August 3, 2025), AGIO TTM earnings before interest & taxes is -$440.29 million, with the most recent change of -$14.56 million (-3.42%) on March 31, 2025.
- Over the past year, AGIO TTM EBIT has dropped by -$47.35 million (-12.05%).
- AGIO TTM EBIT is now -8264.25% below its all-time high of -$5.26 million, reached on March 31, 2012.
Performance
AGIO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AGIO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.8% | -15.8% | -12.1% |
| 3 y3 years | -12.5% | -5.4% | -13.4% |
| 5 y5 years | -34.6% | -22.5% | -55.2% |
AGIO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -12.5% | at low | -17.7% | +14.7% | -17.5% | at low |
| 5 y | 5-year | -34.6% | at low | -32.8% | +14.7% | -70.8% | at low |
| alltime | all time | -2459.9% | at low | -3423.8% | +14.7% | -8264.3% | at low |
AGIO EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$106.63M(-14.7%) | -$440.29M(+3.4%) |
| Dec 2024 | -$425.74M(+8.7%) | -$125.04M(+21.6%) | -$425.74M(+4.6%) |
| Sep 2024 | - | -$102.81M(-2.8%) | -$406.98M(+0.5%) |
| Jun 2024 | - | -$105.82M(+14.9%) | -$405.06M(+3.1%) |
| Mar 2024 | - | -$92.07M(-13.4%) | -$392.95M(+0.4%) |
| Dec 2023 | -$391.49M(+0.6%) | -$106.28M(+5.3%) | -$391.49M(+1.8%) |
| Sep 2023 | - | -$100.90M(+7.7%) | -$384.38M(+2.6%) |
| Jun 2023 | - | -$93.70M(+3.4%) | -$374.57M(-1.0%) |
| Mar 2023 | - | -$90.61M(-8.6%) | -$378.51M(-2.7%) |
| Dec 2022 | -$389.05M(+2.8%) | -$99.17M(+8.9%) | -$389.05M(-1.4%) |
| Sep 2022 | - | -$91.09M(-6.7%) | -$394.70M(-0.0%) |
| Jun 2022 | - | -$97.64M(-3.5%) | -$394.76M(+1.7%) |
| Mar 2022 | - | -$101.14M(-3.5%) | -$388.35M(+2.6%) |
| Dec 2021 | -$378.42M(+12.7%) | -$104.83M(+15.0%) | -$378.42M(+5.4%) |
| Sep 2021 | - | -$91.15M(-0.1%) | -$358.92M(+3.1%) |
| Jun 2021 | - | -$91.22M(+0.0%) | -$348.06M(+2.3%) |
| Mar 2021 | - | -$91.22M(+6.9%) | -$340.10M(+1.2%) |
| Dec 2020 | -$335.92M(+6.2%) | -$85.33M(+6.3%) | -$335.92M(+30.3%) |
| Sep 2020 | - | -$80.29M(-3.6%) | -$257.73M(-9.1%) |
| Jun 2020 | - | -$83.26M(-4.3%) | -$283.61M(-8.6%) |
| Mar 2020 | - | -$87.03M(+1117.7%) | -$310.22M(-3.3%) |
| Dec 2019 | -$316.27M(-8.6%) | -$7.15M(-93.3%) | -$320.67M(-18.5%) |
| Sep 2019 | - | -$106.17M(-3.4%) | -$393.43M(+1.8%) |
| Jun 2019 | - | -$109.87M(+12.7%) | -$386.42M(+10.6%) |
| Mar 2019 | - | -$97.48M(+22.0%) | -$349.50M(+1.0%) |
| Dec 2018 | -$346.03M | -$79.91M(-19.4%) | -$346.03M(-2.9%) |
| Sep 2018 | - | -$99.16M(+35.9%) | -$356.25M(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$72.95M(-22.4%) | -$336.11M(-3.4%) |
| Mar 2018 | - | -$94.01M(+4.3%) | -$347.76M(+8.4%) |
| Dec 2017 | -$320.79M(+59.6%) | -$90.13M(+14.1%) | -$320.79M(+11.4%) |
| Sep 2017 | - | -$79.02M(-6.6%) | -$288.07M(+5.7%) |
| Jun 2017 | - | -$84.60M(+26.2%) | -$272.57M(+11.5%) |
| Mar 2017 | - | -$67.05M(+16.8%) | -$244.44M(+21.6%) |
| Dec 2016 | -$200.99M(+69.3%) | -$57.41M(-9.6%) | -$200.99M(+9.0%) |
| Sep 2016 | - | -$63.51M(+12.5%) | -$184.47M(+14.3%) |
| Jun 2016 | - | -$56.47M(+139.3%) | -$161.44M(+17.8%) |
| Mar 2016 | - | -$23.59M(-42.3%) | -$137.10M(+15.5%) |
| Dec 2015 | -$118.70M(+119.3%) | -$40.90M(+1.0%) | -$118.70M(+13.6%) |
| Sep 2015 | - | -$40.48M(+26.0%) | -$104.53M(+71.8%) |
| Jun 2015 | - | -$32.13M(+518.5%) | -$60.85M(+29.3%) |
| Mar 2015 | - | -$5.20M(-80.6%) | -$47.04M(-13.1%) |
| Dec 2014 | -$54.13M(+39.2%) | -$26.73M(-933.1%) | -$54.13M(+36.5%) |
| Sep 2014 | - | $3.21M(-117.5%) | -$39.65M(-26.5%) |
| Jun 2014 | - | -$18.33M(+49.2%) | -$53.92M(+22.2%) |
| Mar 2014 | - | -$12.28M(+0.3%) | -$44.12M(+13.5%) |
| Dec 2013 | -$38.88M(+69.1%) | -$12.24M(+10.6%) | -$38.88M(+17.3%) |
| Sep 2013 | - | -$11.07M(+29.8%) | -$33.14M(+21.9%) |
| Jun 2013 | - | -$8.53M(+21.0%) | -$27.18M(+9.7%) |
| Mar 2013 | - | -$7.05M(+8.5%) | -$24.78M(+7.7%) |
| Dec 2012 | -$23.00M(+38.3%) | -$6.50M(+27.1%) | -$22.99M(+39.4%) |
| Sep 2012 | - | -$5.11M(-16.5%) | -$16.50M(+44.9%) |
| Jun 2012 | - | -$6.12M(+16.3%) | -$11.39M(+116.3%) |
| Mar 2012 | - | -$5.26M | -$5.26M |
| Dec 2011 | -$16.63M | - | - |
FAQ
- What is Agios Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Agios Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Agios Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Agios Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of AGIO is -$425.74M
What is the all time high annual EBIT for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is -$16.63M
What is Agios Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, AGIO annual earnings before interest & taxes has changed by -$34.25M (-8.75%)
What is Agios Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of AGIO is -$106.63M
What is the all time high quarterly EBIT for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $3.21M
What is Agios Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, AGIO quarterly earnings before interest & taxes has changed by -$14.56M (-15.81%)
What is Agios Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of AGIO is -$440.29M
What is the all time high TTM EBIT for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is -$5.26M
What is Agios Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, AGIO TTM earnings before interest & taxes has changed by -$47.35M (-12.05%)